Annika Åstrand
Annika Åstrand
RIA iMed, AstraZeneca
Verified email at
Cited by
Cited by
Glycolytic flux is conditionally correlated with ATP concentration in Saccharomyces cerevisiae: a chemostat study under carbon-or nitrogen-limiting conditions
C Larsson, A Nilsson, A Blomberg, L Gustafsson
Journal of Bacteriology 179 (23), 7243-7250, 1997
Design, synthesis, and biological activities of four angiotensin II receptor ligands with γ-turn mimetics replacing amino acid residues 3− 5
B Schmidt, S Lindman, W Tong, G Lindeberg, A Gogoll, Z Lai, ...
Journal of medicinal chemistry 40 (6), 903-919, 1997
Mice lacking melanin-concentrating hormone receptor 1 demonstrate increased heart rate associated with altered autonomic activity
A Astrand, M Bohlooly-Y, S Larsdotter, M Mahlapuu, H Andersén, ...
American Journal of Physiology-Regulatory, Integrative and Comparative …, 2004
Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibition
ABM Åstrand, M Hemmerling, J Root, C Wingren, J Pesic, E Johansson, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 308 (1 …, 2015
Postnatal time frame for renal vulnerability to enalapril in rats
G Guron, N Marcussen, A Nilsson, B Sundelin, P Friberg
Journal of the American Society of Nephrology 10 (7), 1550-1560, 1999
Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1
JG Kettle, A Åstrand, M Catley, NP Grimster, M Nilsson, Q Su, R Woessner
Expert Opinion on Therapeutic Patents 27 (2), 127-143, 2017
Alopecia areata and the gut—the link opens up for novel therapeutic interventions
A Borde, A Åstrand
Expert opinion on therapeutic targets 22 (6), 503-511, 2018
Carbon Starvation Can Induce Energy Deprivation and Loss of Fermentative Capacity in Saccharomyces cerevisiae
E Thomsson, C Larsson, E Albers, A Nilsson, CJ Franzén, L Gustafsson
Applied and environmental microbiology 69 (6), 3251-3257, 2003
Mechanisms of impaired urinary concentrating ability in adult rats treated neonatally with enalapril
Acta physiologica scandinavica 165 (1), 103-112, 1999
Attached stratified mucus separates bacteria from the epithelial cells in COPD lungs
JA Fernández-Blanco, D Fakih, L Arike, AM Rodríguez-Piñeiro, ...
JCI insight 3 (17), 2018
Osteoporosis in MCHR1-deficient mice
M Bohlooly-Y, M Mahlapuu, H Andersén, A Åstrand, S Hjorth, L Svensson, ...
Biochemical and biophysical research communications 318 (4), 964-969, 2004
Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the …
FN Hamed, A Åstrand, M Bertolini, A Rossi, A Maleki-Dizaji, ...
PLoS One 14 (7), e0210308, 2019
Dapagliflozin‐lowered blood glucose reduces respiratory Pseudomonas aeruginosa infection in diabetic mice
A Åstrand, C Wingren, A Benjamin, JS Tregoning, JP Garnett, H Groves, ...
British Journal of Pharmacology 174 (9), 836-847, 2017
Molecular identification of GPR55 as a third G protein-coupled receptor responsive to cannabinoid ligands
AJ Brown, S Ueno, K Suen, SJ Dowell, A Wise
Symposium on the Cannabinoids, 24-27, 2005
The catabolic capacity of Saccharomyces cerevisiae is preserved to a higher extent during carbon compared to nitrogen starvation
A Nilsson, IL Påhlman, PÅ Jovall, A Blomberg, C Larsson, L Gustafsson
Yeast 18 (15), 1371-1381, 2001
IGF-I treatment attenuates renal abnormalities induced by neonatal ACE inhibition
ABM Nilsson, N Nitescu, Y Chen, GS Guron, N Marcussen, GL Matejka, ...
American Journal of Physiology-Regulatory, Integrative and Comparative …, 2000
Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach
SK Walsh, CY Hepburn, O Keown, A Åstrand, A Lindblom, E Ryberg, ...
Pharmacology research & perspectives 3 (3), e00143, 2015
Isoindolinone compounds active as Kv1. 5 blockers identified using a multicomponent reaction approach
J Kajanus, I Jacobson, A Åstrand, RI Olsson, U Gran, A Björe, O Fjellström, ...
Bioorganic & medicinal chemistry letters 26 (8), 2023-2029, 2016
Synthesis and evaluation of diphenylphosphinic amides and diphenylphosphine oxides as inhibitors of Kv1. 5
RI Olsson, I Jacobson, J Boström, T Fex, A Björe, C Olsson, J Sundell, ...
Bioorganic & medicinal chemistry letters 23 (3), 706-710, 2013
Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2
QSRW Jason G. Kettle, Annika Åstrand, Matthew Catley, Neil P. Grimster ...
Expert Opinion on Therapeutic Patents 27 (2), 145-161, 2016
The system can't perform the operation now. Try again later.
Articles 1–20